CHCHD1
gene geneOn this page
Also known as FLJ25854mS37
Summary
CHCHD1 (coiled-coil-helix-coiled-coil-helix domain containing 1, HGNC:23518) is a protein-coding gene on chromosome 10q22.2, encoding Small ribosomal subunit protein mS37 (Q96BP2). It is a selective cancer dependency (DepMap: 70.9% of cell lines).
Enables RNA binding activity. Predicted to be involved in mitochondrial translation. Located in cytosol; mitochondrion; and nuclear lumen.
Source: NCBI Gene 118487 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 19 total
- Cancer dependency (DepMap): dependent in 70.9% of screened cell lines
- MANE Select transcript:
NM_203298
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23518 |
| Approved symbol | CHCHD1 |
| Name | coiled-coil-helix-coiled-coil-helix domain containing 1 |
| Location | 10q22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25854, mS37 |
| Ensembl gene | ENSG00000172586 |
| Ensembl biotype | protein_coding |
| OMIM | 608842 |
| Entrez | 118487 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000372833, ENST00000372837
RefSeq mRNA: 1 — MANE Select: NM_203298
NM_203298
CCDS: CCDS7334
Canonical transcript exons
ENST00000372833 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001184105 | 73782323 | 73782441 |
| ENSE00001184112 | 73783074 | 73783652 |
| ENSE00001184116 | 73782048 | 73782199 |
Expression profiles
Bgee: expression breadth ubiquitous, 245 present calls, max score 95.97.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 59.3196 / max 441.0488, expressed in 1826 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 105548 | 59.3196 | 1826 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 95.97 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 95.18 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.76 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.37 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.33 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 94.24 | gold quality |
| oral cavity | UBERON:0000167 | 93.97 | gold quality |
| ileal mucosa | UBERON:0000331 | 93.68 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 93.50 | gold quality |
| colonic mucosa | UBERON:0000317 | 93.41 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 93.31 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.29 | gold quality |
| esophagus mucosa | UBERON:0002469 | 93.28 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 93.18 | gold quality |
| apex of heart | UBERON:0002098 | 93.16 | gold quality |
| adult organism | UBERON:0007023 | 93.09 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 93.00 | gold quality |
| tibialis anterior | UBERON:0001385 | 92.96 | gold quality |
| metanephros | UBERON:0000081 | 92.95 | gold quality |
| biceps brachii | UBERON:0001507 | 92.92 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.85 | gold quality |
| muscle of leg | UBERON:0001383 | 92.80 | gold quality |
| gingiva | UBERON:0001828 | 92.74 | gold quality |
| gingival epithelium | UBERON:0001949 | 92.68 | gold quality |
| monocyte | CL:0000576 | 92.67 | gold quality |
| corpus epididymis | UBERON:0004359 | 92.64 | gold quality |
| leukocyte | CL:0000738 | 92.62 | gold quality |
| adrenal cortex | UBERON:0001235 | 92.58 | gold quality |
| parotid gland | UBERON:0001831 | 92.58 | silver quality |
| heart left ventricle | UBERON:0002084 | 92.46 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.80 |
| E-MTAB-7606 | no | 560.86 |
| E-MTAB-6524 | no | 339.38 |
| E-MTAB-7303 | no | 148.92 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting CHCHD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-5003-5P | 99.61 | 69.13 | 1624 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-105-5P | 99.54 | 69.24 | 2060 |
| HSA-MIR-7853-5P | 99.54 | 69.30 | 2055 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-6768-3P | 99.14 | 67.38 | 1319 |
| HSA-MIR-224-3P | 98.91 | 68.42 | 1815 |
| HSA-MIR-522-3P | 98.91 | 68.56 | 1817 |
| HSA-MIR-34C-3P | 98.11 | 65.60 | 858 |
| HSA-MIR-6847-5P | 97.93 | 66.74 | 1808 |
| HSA-MIR-6781-3P | 97.44 | 66.85 | 970 |
| HSA-MIR-148B-5P | 97.29 | 66.30 | 992 |
| HSA-MIR-6874-3P | 97.29 | 66.34 | 975 |
| HSA-MIR-2682-3P | 97.10 | 66.16 | 840 |
| HSA-MIR-3152-5P | 96.98 | 66.88 | 819 |
| HSA-MIR-616-3P | 96.82 | 66.99 | 784 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 70.9% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 2)
- C2360, a nuclear protein expressed in cytotrophoblasts, is a representative member of a multifamily of proteins, sharing a protein domain that is conserved in eukaryotes. (PMID:15177562)
- CHCHD1 mutations could not explain phenotype of patients with combined oxidative phosphorylation system deficiencies. (PMID:24137763)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | chchd1 | ENSDARG00000029100 |
| mus_musculus | Chchd1 | ENSMUSG00000063787 |
| rattus_norvegicus | Chchd1 | ENSRNOG00000009297 |
| drosophila_melanogaster | CG12848 | FBGN0040666 |
| caenorhabditis_elegans | WBGENE00016057 |
Protein
Protein identifiers
Small ribosomal subunit protein mS37 — Q96BP2 (reviewed: Q96BP2)
Alternative names: 28S ribosomal protein S37, mitochondrial, Coiled-coil-helix-coiled-coil-helix domain-containing protein 1, Nuclear protein C2360
All UniProt accessions (2): Q96BP2, A6NJX6
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion. Nucleus.
Similarity. Belongs to the mitochondrion-specific ribosomal protein mS37 family.
RefSeq proteins (1): NP_976043* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009069 | Cys_alpha_HP_mot_SF | Homologous_superfamily |
| IPR010625 | CHCH | Domain |
| IPR033620 | Ribosomal_mS37_met | Family |
Pfam: PF06747
UniProt features (10 total): helix 3, short sequence motif 2, disulfide bond 2, chain 1, domain 1, turn 1
Structure
Experimental structures (PDB)
57 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9HFM | ELECTRON MICROSCOPY | 3 |
| 9UWH | ELECTRON MICROSCOPY | 3 |
| 9PGI | ELECTRON MICROSCOPY | 3.02 |
| 8QRM | ELECTRON MICROSCOPY | 3.05 |
| 9PG8 | ELECTRON MICROSCOPY | 3.06 |
| 9PS7 | ELECTRON MICROSCOPY | 3.08 |
| 7PO2 | ELECTRON MICROSCOPY | 3.09 |
| 8OIR | ELECTRON MICROSCOPY | 3.1 |
| 9HFO | ELECTRON MICROSCOPY | 3.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96BP2-F1 | 92.51 | 0.81 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 45–76, 55–66
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
MSigDB gene sets: 95 (showing top):
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, WTGAAAT_UNKNOWN, GOCC_MITOCHONDRIAL_ENVELOPE, BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, ACEVEDO_LIVER_CANCER_UP, GOCC_RIBOSOME, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (1): mitochondrial translation (GO:0032543)
GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (10): fibrillar center (GO:0001650), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial small ribosomal subunit (GO:0005763), cytosol (GO:0005829), nucleus (GO:0005634), mitochondrial ribosome (GO:0005761), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 2 |
| intracellular membrane-bounded organelle | 2 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| nucleolus | 1 |
| nuclear lumen | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
2520 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CHCHD1 | MRPL47 | Q9HD33 | 625 |
| CHCHD1 | PTCD3 | Q96EY7 | 604 |
| CHCHD1 | A0A2R8YDH4 | A0A2R8YDH4 | 580 |
| CHCHD1 | MRPL42 | Q9Y6G3 | 525 |
| CHCHD1 | METTL17 | Q9H7H0 | 519 |
| CHCHD1 | RTP2 | Q5QGT7 | 491 |
| CHCHD1 | AURKAIP1 | Q9NWT8 | 489 |
| CHCHD1 | GADD45GIP1 | Q8TAE8 | 479 |
| CHCHD1 | TTLL1 | O95922 | 473 |
| CHCHD1 | MTG1 | Q9BT17 | 463 |
| CHCHD1 | ADAD1 | Q96M93 | 458 |
| CHCHD1 | FASTKD1 | Q53R41 | 447 |
| CHCHD1 | HTD2 | P86397 | 446 |
| CHCHD1 | OXA1L | Q15070 | 442 |
| CHCHD1 | CPNE2 | Q96FN4 | 419 |
IntAct
30 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CHCHD1 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MESD | CHCHD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CHCHD1 | rev | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBY1 | CFAP410 | psi-mi:“MI:0914”(association) | 0.510 |
| rev | TMED10 | psi-mi:“MI:0914”(association) | 0.460 |
| CHCHD1 | RCN2 | psi-mi:“MI:0914”(association) | 0.350 |
| CHCHD1 | ALDH1L1 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
| RBM39 | RPS3A | psi-mi:“MI:0914”(association) | 0.350 |
| GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 | |
| HNRNPDL | psi-mi:“MI:0914”(association) | 0.350 | |
| SUPT5H | psi-mi:“MI:0914”(association) | 0.350 | |
| GTPBP1 | psi-mi:“MI:0914”(association) | 0.350 | |
| rev | MPG | psi-mi:“MI:0914”(association) | 0.350 |
| EIF3F | psi-mi:“MI:0914”(association) | 0.350 | |
| RPS10-NUDT3 | psi-mi:“MI:0914”(association) | 0.350 | |
| PHF20L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL58 | psi-mi:“MI:0914”(association) | 0.350 | |
| MRPL18 | psi-mi:“MI:0915”(physical association) | 0.320 | |
| CHCHD1 | CBY1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CHCHD1 | SDCBP2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CHCHD1 | MESD | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (248): CHCHD1 (Affinity Capture-MS), PPM1K (Affinity Capture-MS), NRD1 (Affinity Capture-MS), IDE (Affinity Capture-MS), CHCHD4 (Affinity Capture-MS), PMPCA (Affinity Capture-MS), CBY1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Affinity Capture-MS), CHCHD1 (Two-hybrid), CHCHD1 (Two-hybrid), AATF (Proximity Label-MS), ACAD9 (Proximity Label-MS), ACOT1 (Proximity Label-MS)
ESM2 similar proteins: A1CH57, A5DUN2, A6ZMQ6, A9ULB4, B3LM82, B5RTE0, C8ZF59, G2TRP6, P00429, P0CM70, P0CM71, P0CM86, P0CM87, P0CT19, P21976, P56277, P90789, Q02373, Q05809, Q0P451, Q0UWF1, Q17Q91, Q1DJH5, Q208S3, Q2M2S5, Q2TAP8, Q3E7A9, Q3E846, Q462Q7, Q4IAJ1, Q4R374, Q53CG4, Q5B4S6, Q6C4R1, Q6CIT9, Q6DD38, Q6FQX5, Q6INR6, Q75D94, Q7S4H6
Diamond homologs: Q96BP2, Q9CQA6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| CHCHD1 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 14 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
274 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:73782218:G:GT | donor_gain | 1.0000 |
| 10:73782233:G:GT | donor_gain | 1.0000 |
| 10:73782195:GGGCG:G | donor_gain | 0.9900 |
| 10:73782196:GGCGG:G | donor_gain | 0.9900 |
| 10:73782240:GAGCA:G | donor_gain | 0.9900 |
| 10:73782474:A:T | donor_gain | 0.9900 |
| 10:73782197:GCG:G | donor_gain | 0.9800 |
| 10:73782239:G:GT | donor_gain | 0.9800 |
| 10:73782473:G:GT | donor_gain | 0.9800 |
| 10:73782196:GGCG:G | donor_gain | 0.9700 |
| 10:73782197:GCGG:G | donor_gain | 0.9700 |
| 10:73782233:G:T | donor_gain | 0.9700 |
| 10:73782197:G:T | donor_gain | 0.9600 |
| 10:73782200:G:GG | donor_gain | 0.9600 |
| 10:73782253:G:T | donor_gain | 0.9500 |
| 10:73782321:A:AG | acceptor_gain | 0.9500 |
| 10:73782322:G:C | acceptor_gain | 0.9500 |
| 10:73782322:G:GG | acceptor_gain | 0.9500 |
| 10:73782242:GCA:G | donor_gain | 0.9400 |
| 10:73782322:GAGGC:G | acceptor_gain | 0.9400 |
| 10:73782212:A:AG | donor_gain | 0.9300 |
| 10:73782213:G:GG | donor_gain | 0.9300 |
| 10:73782244:A:AG | donor_gain | 0.9300 |
| 10:73782437:CTCAG:C | donor_loss | 0.9300 |
| 10:73782438:TCAGG:T | donor_loss | 0.9300 |
| 10:73782439:CAG:C | donor_loss | 0.9300 |
| 10:73782440:AG:A | donor_loss | 0.9300 |
| 10:73782441:GGT:G | donor_loss | 0.9300 |
| 10:73782442:GTGAC:G | donor_loss | 0.9300 |
| 10:73782443:T:C | donor_loss | 0.9300 |
AlphaMissense
765 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:73782379:T:C | F61L | 0.987 |
| 10:73782381:C:A | F61L | 0.987 |
| 10:73782381:C:G | F61L | 0.987 |
| 10:73782366:G:C | W56C | 0.985 |
| 10:73782366:G:T | W56C | 0.985 |
| 10:73782364:T:A | W56R | 0.980 |
| 10:73782364:T:C | W56R | 0.980 |
| 10:73782416:T:C | F73S | 0.973 |
| 10:73782331:T:C | C45R | 0.966 |
| 10:73782415:T:C | F73L | 0.964 |
| 10:73782417:C:A | F73L | 0.964 |
| 10:73782417:C:G | F73L | 0.964 |
| 10:73782380:T:G | F61C | 0.961 |
| 10:73782346:T:C | S50P | 0.960 |
| 10:73782380:T:C | F61S | 0.960 |
| 10:73782331:T:A | C45S | 0.959 |
| 10:73782332:G:C | C45S | 0.959 |
| 10:73782344:T:C | M49T | 0.959 |
| 10:73782394:T:A | C66S | 0.958 |
| 10:73782395:G:C | C66S | 0.958 |
| 10:73782365:G:C | W56S | 0.957 |
| 10:73783161:T:C | F111L | 0.954 |
| 10:73783163:T:A | F111L | 0.954 |
| 10:73783163:T:G | F111L | 0.954 |
| 10:73782344:T:G | M49R | 0.953 |
| 10:73782356:T:C | M53T | 0.952 |
| 10:73782358:G:C | A54P | 0.949 |
| 10:73782332:G:A | C45Y | 0.948 |
| 10:73782395:G:A | C66Y | 0.948 |
| 10:73782361:T:C | C55R | 0.946 |
dbSNP variants (sampled 300 via entrez): RS1000729400 (10:73781508 A>G), RS1001097920 (10:73781165 A>G), RS1001631817 (10:73780309 TAAA>T,TA,TAA,TAAAA), RS1002900966 (10:73781832 G>A,C), RS1002922317 (10:73783478 G>A,C,T), RS1003492777 (10:73783719 G>A), RS1003715034 (10:73781865 C>A,G,T), RS1004549546 (10:73780701 C>T), RS1004582133 (10:73781020 G>A), RS1004980964 (10:73780239 G>T), RS1006148862 (10:73783823 G>T), RS1007822866 (10:73782104 T>G), RS1008158160 (10:73780741 G>C), RS1008943274 (10:73781017 C>T), RS1011029310 (10:73783610 C>T)
Disease associations
OMIM: gene MIM:608842 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004132_74 | Crohn’s disease | 2.000000e-09 |
| GCST007656_13 | Chronic obstructive pulmonary disease or resting heart rate (pleiotropy) | 2.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression, decreases expression | 3 |
| bisphenol A | affects expression, decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| nivalenol | decreases expression | 1 |
| epigallocatechin gallate | decreases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| K 7174 | decreases expression | 1 |
| ICG 001 | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| beta-Naphthoflavone | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Genistein | decreases expression, increases reaction | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.